✦ LIBER ✦

P-396 Treatment of malignant pleural mesothelioma with platinum-pemetrexed chemotherapy: The Leuven Lung Cancer Group experience

✍ Scribed by Dooms, C.; Nackaerts, K.; Vansteenkiste, J.; Nafteux, P.; Schmitt, H.

Book ID: 118573302
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 139 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80889-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo

Combination chemotherapy with Cisplatin

Combination chemotherapy with Cisplatin (CDDP) and Adriamycin (ADM) plus immunotherapy with interferon (IFN) alfa-2b in malignant pleural mesothelioma (MPM): results of a phase II trial of the Italian Group on Rare Tumors (GITR) and Italian Lung Cancer Task Force (FONICAP)

✍ Parra, H.Soto; Bretti, S.; Ardizzoni, A.; Tixi, L.; Latteri, F.; Gravina, A.; Li 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Combined regimen of cisplatin (CDDP), ad

Combined regimen of cisplatin (CDDP), adriamycin (ADM) and a-2b interferon (IFN) in the treatment of advanced malignant pleural mesothelioma (MPM): A phase II multicenter trial of the Italian Group on Rare Tumors and Italian Lung Cancer Task Force (FONICAP)

✍ Santoro, A; Tixi, L; Soto Parra, H.J; Ardizzoni, A; Latteri, F; Bretti, S; Gravi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB